Results for: glaxosmithkline

Royal Bank of Scotland chair moving to drugs firm GSK

Tipperary Station in the Northern Territory ready for 2015 poppy crop

France's Sanofi opens research hub in China

GSK to name RBS's Hampton as new chairman this week

WHO: 1000s of Ebola vaccine doses in coming months

Experimental Ebola vaccines ready by 2015: WHO

IMF unblocks cash as desperate west Africa awaits Ebola aid

Scientists grapple with ethics in rush to release Ebola vaccines

GSK cancer drug combination gets U.S. priority review

China arrests British, American investigators

Chinese crystal meth makers 'used GSK cold medicine'

One dose of HPV vaccine may prevent cervical cancer

South Africa winning malaria fight with DDT help: report

UK's GlaxoSmithKline aims to market first malaria vaccine

GSK distances itself from employees in China probe

Japan's top drugmaker appoints first foreign boss

Cameron heads to China aiming to end Dalai Lama row

GSK recalls kids Panadol

India announces low-cost rotavirus vaccine

GSK in $350 million deal to develop cancer drugs with UK biotech firm

New drugs may make a dent in lung, ovarian cancer

Japan drugmaker Takeda says will fight $6.0 bn US damages order

Chinese police to brief media on GlaxoSmithKline on Wednesday amid probe

Study shows Glaxo heart drug which failed trial has potential benefit

GSK open to selling healthcare business

Sex video new twist in GSK China bribery scandal

Sex video is new twist in GSK China bribery scandal

Race on for Ebola drug

Ebola vaccine trials being fast-tracked: researchers

Nigeria monitoring 400 contacts of doctor who died of Ebola

Cost a focus as GSK takes lead in new wave of biotech lung drugs

Amid Grave Ebola Estimates, US to Test Vaccine

Exclusive: GSK China consumer healthcare unit linked to DOJ probe in 2012

Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Glaxo says China drugs sales slump on bribery probe

Europe's drugmakers fight off generics

Exclusive: Bayer, Novartis, others eye Merck's consumer health unit -...

FDA panel backs inhaler drug for lung disease